272 related articles for article (PubMed ID: 12438296)
21. Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR-/- mice.
Li G; Chen C; Laing SD; Ballard C; Biju KC; Reddick RL; Clark RA; Li S
Gene Ther; 2016 Jan; 23(1):78-85. PubMed ID: 26204499
[TBL] [Abstract][Full Text] [Related]
22. Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration.
Yamashita T; Kawashima S; Ozaki M; Namiki M; Inoue N; Hirata K; Yokoyama M
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):969-74. PubMed ID: 12067906
[TBL] [Abstract][Full Text] [Related]
23. Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe.
Sato K; Nakano K; Katsuki S; Matoba T; Osada K; Sawamura T; Sunagawa K; Egashira K
J Atheroscler Thromb; 2012; 19(11):986-98. PubMed ID: 22785139
[TBL] [Abstract][Full Text] [Related]
24. Characterization of monocyte chemoattractant proteins and CC chemokine receptor 2 expression during atherogenesis in apolipoprotein E-null mice.
Zhang S; Wang X; Zhang L; Yang X; Pan J; Ren G
J Atheroscler Thromb; 2011; 18(10):846-56. PubMed ID: 21712615
[TBL] [Abstract][Full Text] [Related]
25. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.
Aiello RJ; Bourassa PA; Lindsey S; Weng W; Natoli E; Rollins BJ; Milos PM
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1518-25. PubMed ID: 10364084
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
Schönbeck U; Sukhova GK; Shimizu K; Mach F; Libby P
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7458-63. PubMed ID: 10861012
[TBL] [Abstract][Full Text] [Related]
27. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
28. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
29. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
30. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis.
Egashira K; Koyanagi M; Kitamoto S; Ni W; Kataoka C; Morishita R; Kaneda Y; Akiyama C; Nishida KI; Sueishi K; Takeshita A
FASEB J; 2000 Oct; 14(13):1974-8. PubMed ID: 11023981
[TBL] [Abstract][Full Text] [Related]
31. MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Peterson KE; Errett JS; Wei T; Dimcheff DE; Ransohoff R; Kuziel WA; Evans L; Chesebro B
J Virol; 2004 Jun; 78(12):6449-58. PubMed ID: 15163738
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice.
Ishibashi M; Egashira K; Zhao Q; Hiasa K; Ohtani K; Ihara Y; Charo IF; Kura S; Tsuzuki T; Takeshita A; Sunagawa K
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):e174-8. PubMed ID: 15331433
[TBL] [Abstract][Full Text] [Related]
33. Monocyte chemoattractant protein-1 involvement in the alpha-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice.
Peluzio MC; Miguel E; Drumond TC; César GC; Santiago HC; Teixeira MM; Vieira EC; Arantes RM; Alvarez-Leite JI
Br J Nutr; 2003 Jul; 90(1):3-11. PubMed ID: 12844369
[TBL] [Abstract][Full Text] [Related]
34. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice.
Braunersreuther V; Steffens S; Arnaud C; Pelli G; Burger F; Proudfoot A; Mach F
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1090-6. PubMed ID: 18388327
[TBL] [Abstract][Full Text] [Related]
35. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice.
Burleigh ME; Babaev VR; Yancey PG; Major AS; McCaleb JL; Oates JA; Morrow JD; Fazio S; Linton MF
J Mol Cell Cardiol; 2005 Sep; 39(3):443-52. PubMed ID: 16040051
[TBL] [Abstract][Full Text] [Related]
37. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy.
Saiura A; Sata M; Hiasa K; Kitamoto S; Washida M; Egashira K; Nagai R; Makuuchi M
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1886-90. PubMed ID: 15284091
[TBL] [Abstract][Full Text] [Related]
38. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
39. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.
Michelsen KS; Wong MH; Shah PK; Zhang W; Yano J; Doherty TM; Akira S; Rajavashisth TB; Arditi M
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10679-84. PubMed ID: 15249654
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice.
Aiello RJ; Bourassa PA; Lindsey S; Weng W; Freeman A; Showell HJ
Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):443-9. PubMed ID: 11884288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
